Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Autor:
Maria Polina Konstantinou, Sé Bastien Calbo, Vivien Hébert, Martine Avenel-Audran, Catherine Prost-Squarcioni, Pierre Vabres, Christophe Bedane, Michel D'Incan, Laurent Misery, C. Mignard, Marie Beylot-Barry, Estelle Houivet, Sophie Duvert-Lehembre, Bruno Sassolas, Marina Alexandre, Guillaume Chaby, Jean-David Bouaziz, Emmanuel Delaporte, Maud Maho-Vaillant, Olivier Dereure, Philippe Bernard, Denis Jullien, Pierre Balayé, Frédéric Caux, Marie-Aleth Richard, Jacques Benichou, Gaëlle Quéreux, Catherine Picard-Dahan, Nathalie Beneton, Bruno Labeille, Pascal Joly, Laurent Machet, Saskia Ingen-Housz-Oro, Sébastien Debarbieux, Alain Dupuy, Nicolas Dupin, Marie-Laure Golinski
Publikováno v:
JAMA Dermatol
Importance Rituximab and short-term corticosteroid therapy are the criterion standard treatments for patients with newly diagnosed moderate to severe pemphigus. Objective To examine factors associated with short-term relapse in patients with pemphigu
Publikováno v:
JAMA Dermatology. 153:1302
Importance Brentuximab vedotin is a monomethyl auristatin E–conjugated monoclonal antibody directed against CD30. It represents a potential treatment for the CD30+lymphoproliferative disorder lymphomatoid papulosis (LyP), which currently has no app
Autor:
Ashish C. Bhatia, Shilpi Khetarpal, Lucia Z. Diaz, Marla N. Jahnke, Albert C. Yan, Heidi Prather, Mara Weinstein Velez, C. William Hanke, Abel Torres, James Q Del Rosso, Jeremy A. Brauer, Leah K. Spring, Geoffrey C. Gurtner, Girish S. Munavalli, Abigail Waldman, Moise L. Levy, Kristen M. Kelly, Peter R. Shumaker, Joel L Cohen, Elizabeth L. Tanzi, Andrea L. Zaenglein, Lawrence F. Eichenfield, Murad Alam, Jeffrey S. Dover, Michael T. Longaker, Andrew C. Krakowski, Megan A. Kinney, David M. Ozog, James J. Leyden
Publikováno v:
JAMA Dermatology. 153:802
Importance The notion that systemic isotretinoin taken within 6 to 12 months of cutaneous surgery contributes to abnormal scarring or delayed wound healing is widely taught and practiced; however, it is based on 3 small case series from the mid-1980s
Autor:
Daniel Hohl, Olivier Demaria, Nikhil Yawalkar, Curdin Conrad, Laurence Feldmeyer, Emmanuel Laffitte, Anna Mennella, Michel Gilliet, Alessio Mylonas
Publikováno v:
JAMA dermatology, vol. 153, no. 4, pp. 304-308
JAMA Dermatology, Vol. 153, No 4 (2017) pp. 304-308
JAMA Dermatology, Vol. 153, No 4 (2017) pp. 304-308
Importance Treatment of pityriasis rubra pilaris (PRP) is solely based on its resemblance to psoriasis rather than any knowledge of its pathomechanism. Insight into pathogenic mediators of inflammation is essential for targeted and valid treatment op
Publikováno v:
JAMA Dermatology. 152:841
Autor:
David Amato, Emily Edson-Heredia, April W. Armstrong, F.E. Yang, Charles Lynde, Baojin Zhu, Mona Ståhle, Enkeleida Nikaï, S.R. McBride, Kenneth B. Gordon
Publikováno v:
JAMA Dermatology. 152:661
Therapies that reduce psoriasis symptoms may improve work productivity.To assess the effect of ixekizumab therapy on work productivity, measured by the Work Productivity and Activity Impairment-Psoriasis (WPAI-PSO).Three multicenter, randomized doubl